Drugs Made In America Acquisition II Corp. (DMIIU) — S-1/A Filings
All S-1/A filings from Drugs Made In America Acquisition II Corp.. Browse 3 S-1/A reports with AI-powered summaries and risk analysis.
S-1/A Filings (3)
-
DMIIU Files S-1/A for $500M SPAC IPO Targeting Pharma
— Sep 16, 2025 Risk: high
Drugs Made In America Acquisition II Corp. (DMIIU) filed an S-1/A to raise $500 million through an initial public offering of 50,000,000 units at $10.00 per uni -
DMIIU Launches $500M SPAC IPO Targeting Pharma Sector
— Sep 15, 2025 Risk: high
Drugs Made In America Acquisition II Corp. (DMIIU) is a newly incorporated Cayman Islands-based SPAC seeking a business combination, primarily targeting the pha -
Drugs Made In America II Files S-1/A for $500M Pharma SPAC IPO
— Sep 5, 2025 Risk: high
Drugs Made In America Acquisition II Corp. (DMIIU) filed an S-1/A on September 5, 2025, for an initial public offering of 50,000,000 units at $10.00 per unit, a
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX